Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
- PMID: 16497988
- DOI: 10.1161/01.RES.0000215809.47923.fd
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
Abstract
Heterozygous germline mutations in the gene encoding the bone morphogenetic protein type II (BMPR-II) receptor underlie the majority (>70%) of cases of familial pulmonary arterial hypertension (FPAH), and dysfunction of BMP signaling has been implicated in other forms of PAH. The reduced disease gene penetrance in FPAH indicates that other genetic and/or environmental factors may also be required for the clinical manifestation of disease. Of these, the serotonin pathway has been implicated as a major factor in PAH pathogenesis. We investigated the pulmonary circulation of mice deficient in BMPR-II (BMPR2(+/-) mice) and show that pulmonary hemodynamics and vascular morphometry of BMPR2(+/-) mice were similar to wild-type littermate controls under normoxic or chronic hypoxic (2- to 3-week) conditions. However, chronic infusion of serotonin caused increased pulmonary artery systolic pressure, right ventricular hypertrophy, and pulmonary artery remodeling in BMPR2(+/-) mice compared with wild-type littermates, an effect that was exaggerated under hypoxic conditions. In addition, pulmonary, but not systemic, resistance arteries from BMPR2(+/-) mice exhibited increased contractile responses to serotonin mediated by both 5-HT2 and 5-HT1 receptors. Furthermore, pulmonary artery smooth muscle cells from BMPR2(+/-) mice exhibited a heightened DNA synthesis and activation of extracellular signal-regulated kinase 1/2 in response to serotonin compared with wild-type cells. In vitro and in vivo experiments suggested that serotonin inhibits BMP signaling via Smad proteins and the expression of BMP responsive genes. These findings provide the first evidence for an interaction between BMPR-II-mediated signaling and the serotonin pathway, perturbation of which may be critical to the pathogenesis of PAH.
Similar articles
-
Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.Circ Res. 2005 May 27;96(10):1053-63. doi: 10.1161/01.RES.0000166926.54293.68. Epub 2005 Apr 21. Circ Res. 2005. PMID: 15845886
-
Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.Circ Res. 2006 Feb 3;98(2):209-17. doi: 10.1161/01.RES.0000200180.01710.e6. Epub 2005 Dec 15. Circ Res. 2006. PMID: 16357305
-
Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.Hypertens Res. 2010 May;33(5):435-45. doi: 10.1038/hr.2010.16. Epub 2010 Feb 26. Hypertens Res. 2010. PMID: 20186146
-
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?Proc Am Thorac Soc. 2006 Nov;3(8):680-6. doi: 10.1513/pats.200605-118SF. Proc Am Thorac Soc. 2006. PMID: 17065373 Review.
-
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.Exp Physiol. 2013 Aug;98(8):1262-6. doi: 10.1113/expphysiol.2012.069104. Epub 2013 May 3. Exp Physiol. 2013. PMID: 23645549 Review.
Cited by
-
Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression.JACC Basic Transl Sci. 2024 Jun 5;9(7):890-902. doi: 10.1016/j.jacbts.2024.04.006. eCollection 2024 Jul. JACC Basic Transl Sci. 2024. PMID: 39170954 Free PMC article.
-
Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension.Am J Respir Cell Mol Biol. 2007 Jul;37(1):31-7. doi: 10.1165/rcmb.2007-0066TR. Epub 2007 Mar 15. Am J Respir Cell Mol Biol. 2007. PMID: 17363775 Free PMC article. Review.
-
Transglutaminase 2-mediated serotonylation in pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15;306(4):L309-15. doi: 10.1152/ajplung.00321.2013. Epub 2013 Dec 27. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 24375797 Free PMC article. Review.
-
Bone morphogenetic protein signaling protects against cerulein-induced pancreatic fibrosis.PLoS One. 2014 Feb 21;9(2):e89114. doi: 10.1371/journal.pone.0089114. eCollection 2014. PLoS One. 2014. PMID: 24586530 Free PMC article.
-
Pulmonary hypertension: therapeutic targets within the serotonin system.Br J Pharmacol. 2008 Oct;155(4):455-62. doi: 10.1038/bjp.2008.241. Epub 2008 Jun 9. Br J Pharmacol. 2008. PMID: 18536742 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous